Correlation between drug treatment adherence and lithium treatment attitudes and knowledge by bipolar patients

Progress in Neuro-Psychopharmacology and Biological Psychiatry

Volumn 31, Issue 1, 2007, Pages 217-224

  Rosa, Adriane Ribeiro ^a   Marco, Marion ^a   Fachel, Jandyra M G ^b   Kapczinski, Flávio ^b   Stein, Airton Tetelbom ^a   Barros, Helena M T ^a  

^a UNIVERSIDADE FEDERAL DE CIÊNCIAS DA SAÚDE DE PORTO ALEGRE   (Brazil)

^b FEDERAL UNIVERSITY OF RIO GRANDE DO SUL   (Brazil)

Author keywords

Adherence scales; Attitudes; Bipolar disorder; Knowledge; Lithium treatment

Indexed keywords

LITHIUM;

ADULT; AGED; ARTICLE; BIPOLAR DISORDER; DIARRHEA; DIZZINESS; DRUG BLOOD LEVEL; DRUG ERYTHROCYTE LEVEL; FATIGUE; FEMALE; GOITER; HUMAN; HYPOTHYROIDISM; LITHIUM ATTITUDES QUESTIONNAIRE; LITHIUM KNOWLEDGE TEST; MAJOR CLINICAL STUDY; MALE; MEDICATION ADHERENCE RATING SCALE; MENTAL PATIENT; MOOD DISORDER; MOTOR DYSFUNCTION; MUSCLE WEAKNESS; NAUSEA; PATIENT ATTITUDE; PATIENT COMPLIANCE; PHOTOMETER; PLASMA; POLYDIPSIA; POLYURIA; PSYCHOPHARMACOTHERAPY; QUESTIONNAIRE; RATING SCALE; SEXUAL DYSFUNCTION; SIDE EFFECT; SKIN DISEASE; SOMNOLENCE; THYROID DISEASE; TREMOR; VOMITING; WEIGHT GAIN;

ADOLESCENT; ADULT; AGED; ANTIMANIC AGENTS; ATTITUDE; BIPOLAR DISORDER; ERYTHROCYTES; FEMALE; HUMANS; KNOWLEDGE OF RESULTS (PSYCHOLOGY); LITHIUM; LITHIUM CARBONATE; MALE; MIDDLE AGED; PATIENT COMPLIANCE; PATIENT EDUCATION; PHYSICIAN-PATIENT RELATIONS; QUESTIONNAIRES; REGRESSION ANALYSIS;

EID: 33845613946     PISSN: 02785846     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pnpbp.2006.08.007     Document Type: Article

References (31)

1. Akiskal H.S., Bourgeois M.L., Angst J., Post R., Möller H., and Hirschfeld R. Re-evaluating the prevalence of and diagnostic composition within the broad clinical spectrum of bipolar disorders. J Affect Disord 59 1 (2000) S5-S30
2. Burgess, S, Geddes, J, Hawton, K, Townsend, E, Jamison, K, Goodwin, G. Lithium for maintenance treatment of mood disorders, In Cochrane Database Syst. Ver. Oxford. 2002. www.bireme.br.
3. Clarck D.J., and Pickles J. Lithium treatment for people with learning disability: patients' and carers' knowledge of hazards and attitudes to treatment. J Intellect Disabil Res 38 (1994) 187-194
4. Claxton A.J., Cramer J., and Courtney P.A. Systematic review of the association between dose regimens and medication compliance. Clin Ther 23 (2001) 1297-1310
5. Colom F., Vieta E., Reinares M., Martinez-Aran A., Torrent C., Goikolea J.M., et al. A randomized trial on the efficacy of group psychoeducation in the prophylaxis of recurrences in bipolar patients whose disease is in remission. Arch Gen Psychiatry 60 (2003) 402-407
6. Del-Ben C.M., Rodrigues C.R., and Zuardi A.W. Reliability of the Portuguese version of the structured clinical interview for DSM-III-R (SCID) in a Brazilian sample of psychiatric outpatients. Braz J Med Biol Res 29 12 (1996) 1675-1682
7. Dharmendra M.S., and Eagles J.M. Factors associated with patients' knowledge of and attitudes towards treatment with lithium. J Affect Disord 75 (2003) 29-33
8. Frazer A., Mendels J., Brunswuck D., London J., Pring M., Ramsey A., et al. Erythrocyte concentrations of the lithium ion: clinical correlates and mechanisms of action. Am J Psychiatry 9 (1978) 1065-1069
9. Gelenberg A.J., Kane J.M., Keller M.B., Lavori P., Rosenbaum J.F., Cole K., et al. Comparison of standard and low serum levels of lithium for maintenance treatment of bipolar disorder. N Engl J Med 321 (1989) 1489-1493
10. Ghose K. Lithium salts: therapeutic and unwanted effects. Br J Hosp Med 12 (1977) 578-580
11. Harvey S.N. The development and descriptive use of the lithium attitudes questionnaire. J Affect Disord 22 (1991) 211-219
12. Harvey N.S., Summerton A.M., and Forrest A.R.W. New direct method for measuring red cell lithium. J Clin Pathol 42 (1989) 435-437
13. Hopkins H.S., and Gelenberg A.J. Serum lithium levels and the outcome of maintenance therapy of bipolar disorder. Bipolar Disord 2 (2000) 174-179
14. Jonhson R.E., and McFarland B.H. Lithium use and discontinuation in a health maintenance organization. Am J Psychiatry 153 (1996) 993-1000
15. Lingam R., and Scott J. Treatment non-adherence in affective disorders. Acta Psychiatr Scand 105 (2002) 164-172
16. Maj M. The impact of lithium prophylaxis on the course of bipolar disorder: a review of the research evidence. Bipolar Disord 2 (2000) 93-101
17. McCreadie R.G., McCormick M., and Morrison D.P. The impact of lithium in south-west Scotland. Br J Psychiatry 146 (1985) 70-80
18. Mester R., Toren P., Mizrachi I., Wolmer L., Karni N., and Weizman A. Caffeine withdrawal increases lithium blood levels. Biol Psychiatry 37 (1995) 348-350
19. Nilsson A., and Axelsson R. Lithium discontinuers-I. Clinical characteristics and outcome. Acta Psychiatr Scand 82 (1990) 433-438
20. Schaub R.T., Berghoefer A., and Müller-Oerlinghausen B. What do patients in a lithium outpatient clinic know about lithium therapy?. J Psychiatry Neurosci 26 4 (2001) 319-324
21. Schou M. The combat of non-compliance during prophylactic lithium treatment. Acta Psychiatr Scand 95 (1997) 361-363
22. Schou M. Perspectives on lithium treatment of bipolar disorder: action, efficacy, effect on suicidal behavior. Bipolar Disord 1 (1999) 5-10
23. Schumann C., Lenz G., Berghofer A., and Muller-Oerlinghausen B. Non-adherence with long-term prophylaxis: a 6-year naturalistic follow-up study of affectively ill patients. Psychiatr Res 89 (1999) 247-257
24. Scott J., and Pope M. Nonadherence with mood stabilizers: prevalence and predictors. J Clin Psychiatry 63 (2002) 384-390
25. Scott J., and Pope M. Do clinicians understand why individuals stop taking lithium?. J Affect Disord 74 (2003) 287-291
26. Sing Lee W.Y.K., Wing, and Wong K.C. Knowledge and compliance towards lithium therapy among Chinese psychiatry patients in Hong Kong. Aust N Z J Psychiatry 26 (1992) 444-448
27. Sproule B. Lithium in bipolar disorder. Clin Pharmacokinet 41 9 (2002) 639-660
28. Taylor R., Mallinger A.G., Frank E., Rucci P., Stat D., Thase M., et al. Variability of erythrocyte and serum lithium levels correlates with therapist treatment adherence efforts and maintenance treatment outcome. Neuropsychopharmacology 24 (2002) 192-197
29. Thompson K., Kulkarni J., and Sergejew A.A. Reability and validity of a new medication adherence rating scale (MARS) for the psychoses. Schizophr Res 42 (2000) 241-247
30. Waters B., Lapierre Y., and Gagnon A. Determination of the optimal concentration of lithium for the prophylaxis of manic-depressive disorder. Biol Psychiatry 17 (1982) 1323-1329
31. Wong S.S.L., Lee S., and Wat K.H.Y. A preliminary communication of an insight scale in the assessment of lithium non-adherence among Chinese patients in Hong Kong. J Affect Disord 55 (1999) 241-244